Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of MRI for Prostate Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age of patients: up to 80 years.~* Men scheduled for radical prostatectomy due to prostate cancer or men post radical prostatectomy with suspicion of recurrence.~* Patients who are able and willing to give consent and able to have an MRI examination.~Exclusion Criteria:~* Contraindications to MRI including: claustrophobia, weight over 120 kg, implanted ferromagnetic materials or foreign objects, and known intolerance to the MRI contrast agent (e.g. Gadolinium or Dotarem)~* Individuals who are not able or willing to tolerate the required prolonged stationary supine position during imaging (approximately 1 hr.)~* Any rectal pathology preventing probe insertion, (as active proctitis, active ulcerative colitis, fissure ani)~* Any spinal pathology that prohibits maintaining supine position for an hour~* Patients with documented myocardial infarction within one month of protocol entry, and patients with cardiac pacemakers~* Severe cerebrovascular disease (multiple CVA or CVA within 6 months)

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).